Study to evaluate single inhaled doses of PT001, PT003, PT005 and PT001 Plus PT005 in healthy subjects

Study identifier:PT0030901

ClinicalTrials.gov identifier:NCT00893971

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomized, double-blind, single dose, four-period, four-treatment, cross-over study evaluating the safety of PT001, PT003, PT005 administered individually and PT001 + PT005 delivered together in separate inhalers in healthy subjects

Medical condition

Healthy Volunteers

Phase

Phase 1

Healthy volunteers

Yes

Study drug

PT001, PT005, PT003, PT001 + PT005

Sex

All

Actual Enrollment

16

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 May 2009
Primary Completion Date: 01 Jul 2009
Study Completion Date: 01 Jul 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 May 2016 by Pearl Therapeutics, Inc.

Sponsors

Pearl Therapeutics, Inc.

Collaborators

-

Inclusion and exclusion criteria